Connect Biopharma Holdings Limited Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
Connect Biopharma Holdings Limited (CNTB) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of $0.76 per share for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2024-09-05
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 6 month | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|---|
| 2024-06-30 | $0.76 6-K · filed 2024-09-05 | ||
| 2023-12-31 | $0.75 20-F · filed 2024-04-16 | ||
| 2021-12-31 | $0.96 20-F · filed 2024-04-16 | $0.90 20-F · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |